UTERINE CARCINOSARCOMA AFTER ADJUVANT TAMOXIFEN TREATMENT FOR BREAST CANCER

被引：0
|
作者：
Wuntakal, R. [1 ]
Lane, G. [1 ]
Menon, P. [1 ]
机构：
[1] Kings Coll NHS Fdn Trust, Guys & St Thomas NHS Fdn Trust, London, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0467
引用
收藏
页码：1406 / 1406
页数：1
相关论文
共 50 条
  • [1] Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma
    Leung, F.
    Terzibachian, J. -J.
    Govyadovskiy, A.
    Bourtembourg, A.
    Maillet, R.
    Riethmuller, D.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2009, 37 (05): : 447 - 451
  • [2] Uterine malignant mixed Mullerian tumor after adjuvant tamoxifen treatment for breast cancer
    Grigoriadis, C.
    Androutsopoulos, G.
    Zygouris, D.
    Arnogiannaki, N.
    Terzakis, E.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (01) : 94 - 98
  • [3] Synchronous uterine carcinosarcoma and contralateral breast cancer after tamoxifen therapy: a case report
    Shen, Ling
    Hong, Liangli
    Zhang, Guohong
    Mai, Ruiqin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (08): : 5295 - 5301
  • [4] Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer
    Hoogendoorn, Wilhelmina E.
    Hollema, Harry
    van Boven, Hester H.
    Bergman, Elisabeth
    de Leeuw-Mantel, Geri
    Platteel, Inge
    Fles, Renske
    Nederlof, Petra M.
    Mourits, Marian J. E.
    van Leeuwen, Flora E.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (01) : 99 - 108
  • [5] Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer
    Hoogendoorn, W. E.
    Hollema, H.
    Van Boven, H. H.
    Bergman, E.
    De Leeuw-Mantel, G.
    Platteel, I.
    Fles, R.
    Nederlof, R. M.
    Mourits, M. J. E.
    Van Leeuwen, F. E.
    EJC SUPPLEMENTS, 2007, 5 (04): : 161 - 161
  • [6] Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer
    Wilhelmina E. Hoogendoorn
    Harry Hollema
    Hester H. van Boven
    Elisabeth Bergman
    Geri de Leeuw-Mantel
    Inge Platteel
    Renske Fles
    Petra M. Nederlof
    Marian J. E. Mourits
    Flora E. van Leeuwen
    Breast Cancer Research and Treatment, 2008, 112 : 99 - 108
  • [7] The dilemma of adjuvant treatment for uterine carcinosarcoma
    Herbolsheimer, M.
    ONKOLOGE, 2009, 15 (10): : 1031 - 1032
  • [8] UTERINE CARCINOSARCOMA FOLLOWING TAMOXIFEN THERAPY FOR BREAST CANCER: A SERIES OF 11 CASES
    Ben Hamida, K.
    Naija, L.
    Ghalleb, M.
    Bouida, M. A.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A74 - A75
  • [9] A breast cancer patient with pelvic and gastric malignancy after adjuvant tamoxifen treatment for breast cancer
    Dede, M.
    Gezginc, K.
    Ulubay, M.
    Alanbay, I.
    Gueran, S.
    Yenen, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2008, 29 (02) : 200 - 200
  • [10] Tamoxifen versus toremifene in the adjuvant treatment of breast cancer
    Holli, K
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S37 - S38
12345